Vaccine trial halted early in fight against prostate cancer return
NCT ID NCT02772562
Summary
This study tested an experimental vaccine called PROSTVAC-V/F to see if it could stop prostate cancer from coming back after surgery in men at high risk of relapse. The trial was terminated early and enrolled only 33 participants before ending. Researchers aimed to measure how long patients remained cancer-free and assess the vaccine's safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Conditions
Explore the condition pages connected to this study.